India Has Supplied Over 723 Lakh Doses of COVID Vaccines to 94 Countries, Two UN Entities: Centre

The Government of India has so far already supplied 222.56 lakh of COVID-19 vaccine doses to COVAX.

New Delhi: India has supplied over 723 lakh doses of COVID-19 vaccine to 94 countries and two UN entities since the start of the Vaccine Maitri Programme in January this year, the Rajya Sabha was informed on Tuesday.

India supplied COVID-19-related medical and other assistance to over 150 countries since the beginning of the pandemic, minister of state for health Bharati Pravin Pawar said in a written reply to a question in Rajya Sabha.

She said, “Since the start of Vaccine Maitri Programme in January 2021, India has supplied 723.435 lakh doses of Covid vaccine to 94 countries and 2 UN entities in the form of grant, commercial export or through COVAX till November 29, 2021.”

In the fight against the pandemic during the second wave, support in the form of COVID-19-related equipment and medicines were received from more than 50 countries. These included supplies from foreign governments, private companies, Indian associations abroad, etc, Pawar stated.

In reply to a separate question on the government’s response to the call for helping low-income countries, Pawar said the COVAX facility co-led by the World Health Organisation (WHO) has maintained that no effort should be spared to substantially increase vaccine supply for lower-income countries and has called all countries that are well-supplied with COVID-19 vaccines to donate doses to COVAX and on manufacturers to prioritise supplies to COVAX.

The Government of India has so far already supplied 222.56 lakh of COVID-19 vaccine doses to COVAX, she stated.

Time for India To Reinvigorate Vaccine Diplomacy in South Asia

India’s role in providing vaccines to South Asia was pronounced even before the COVID-19 pandemic.

The COVID-19 pandemic has inflicted high costs on the health and socio-economic well-being of people globally. International organisations such as World Health Organisation and World Trade Organisation have unanimously emphasized the importance of international cooperation in ensuring the smooth flow of vaccines and other vital medical supplies across countries. Like many other countries committed to global vaccine cooperation, India was among the forerunners in its ‘vaccine diplomacy’.

Being the world’s third-largest producer of pharmaceuticals, India has supported the global community on several fronts, most notably by launching the “Vaccine Maitri” initiative in January 2021. As per data released by the Ministry of External Affairs, around 6.64 crore doses of the COVID-19 vaccine have been exported to 95 countries, of which 3.58 crore doses were supplied to 26 countries under commercial contracts, 1.07 crore to 47 countries as grants and 1.98 crore to 47 countries under the COVAX facility.

After initially garnering global applause, India recently received severe criticism when the deadly second COVID-19 wave engulfed the country – internally for sending vaccines abroad and from international organisations for reneging on its promises. Because of an internal shortage, the government had to halt the exports of vaccines provisionally, till the time its production is deemed adequate to cater to both the national as well as international communities.

Even though the situation in India remains critical and halting of exports seems to be the only option for now, it is also important to reaffirm the importance of trade in vaccines.

Trade in vaccines

There is a considerable amount of vaccine trade that takes place at the global level. In the last five years, the world trade of vaccines for human medicine has increased by 50% times from $42.91 billion in 2016 to $65.14 billion in 2020. This trend has been mainly driven by advanced economies, such as Belgium, Ireland, France, the US and Italy.

To gain insights into the supply and demand conditions driving the trade in vaccines, let us analyse trade data for the last two years. If we look at 2019, before the COVID-19 pandemic, we find that vaccines were exported by 92 countries but imported by 214 countries. In 2020, vaccines were exported by just 88 countries but again imported by 214 countries. These figures show that the demand for vaccines is much more than the supply. The top ten exporters of vaccines account for 92% of the total exports. It is interesting to note that India was the only developing country to be amongst the top ten exporters of vaccines, both in 2019 and 2020.

Table 1: Top Vaccine Exporters
S. No. Rank of Top Exporters in 2019 Rank of Top Exporters in 2020
1 Belgium Belgium
2 Ireland Ireland
3 France France
4 United Kingdom United States of America
5 United States of America Italy
6 Italy United Kingdom
7 India India
8 Netherlands Poland
9 Poland Netherlands
10 Germany Germany

Source: Trade Map, International Trade Centre

India’s vaccine exports to South Asia

India is also among the key source of vaccine exports for the South Asian region, which is home to about one-fourth of the world’s total population and has been experiencing a deadly surge of COVID-19 infections. As per a UNICEF press release, the region accounts for half of all new known infections globally. The mortality rate has been rising, crippling the existing health sector infrastructure. Trade in vaccines and other important health supplies are important means not just to save lives, but also helps create more robust healthcare systems across South Asia ahead of potential future waves of the pandemic.

As part of India’s vaccine diplomacy, about one-fourth of India’s total COVID vaccine supply has gone to South Asian countries.

The importance of India as a vaccine supplier in South Asia was well established even before the pandemic. The South Asian countries have always been dependent upon India for vaccine supplies for other diseases such as cholera, typhoid, tuberculosis, rabies, measles, mumps and rubella, polio amongst others. Since 2014, India’s exports of vaccines to South Asia have nearly doubled from $16.06 million to $34.53 million in 2018.

Source: Trade Map, International Trade Centre

India’s loss, China’s gain?

Ever since India suspended its vaccine exports, South Asian countries like Bangladesh and Sri Lanka have increased their dependence on China for COVID-19 vaccines. As per reports, China has already given 1.1 million doses of COVID-19 vaccines to Sri Lanka. Bangladesh also received its first donation of half a million vaccines from China in May 2021 and Nepal has been promised an additional one million doses. Analysts view China’s vaccine diplomacy as a means to re-gain traction and influence in the strategic Indian Ocean.

At a time when the COVID-19 crisis and vaccine diplomacy had provided India with a much-needed platform to steer regional cooperation in South Asia, being forced to halt exports on one hand and rising Chinese influence on the other can lead to heavy political and strategic implications. While protecting lives of its own population is definitely a priority, India should ramp up its production capacity to a level that it can possibly resume vaccine deliveries to other countries, most notably its immediate neighbourhood.

Samridhi Bimal is an Independent Consultant. Views expressed are personal.

India’s Halt to Vaccine Exports ‘Very Problematic’ for Africa

The continent’s vaccine targets relied on supplies from the global COVAX vaccine-sharing facility, which has been heavily dependant on AstraZeneca shots produced by the Serum Institute of India.

Addis Ababa: An extended halt to exports of COVID-19 vaccines from India, where authorities are battling a new wave of domestic infections, risks derailing vaccination efforts already underway in Africa, one of the continent’s top health officials said on Tuesday.

India stopped vaccine exports a month ago and, according to a Reuters report earlier on Tuesday, is now unlikely to resume major exports before October, dealing a major setback to the global COVAX initiative on which many poor countries are dependant.

Africa has lagged far behind other regions due to supply issues and meagre financial resources but had planned to vaccinate 30-35% of its population by the end of the year and 60% within the next two to three years.

“This is very problematic as it means unpredictability of our vaccination programmes and a serious risk of not achieving our stated target… on time,” John Nkengasong, director of the Africa Centers for Disease Control and Prevention, wrote to Reuters.

Those targets primarily relied on supplies from the global COVAX vaccine-sharing facility, which has been heavily dependant on AstraZeneca shots produced by the Serum Institute of India (SII).

“Given India’s huge challenges, it will be impossible to expect anything soon,” said Nkengasong.

There have been at least 4,742,000 reported infections and 126,000 reported deaths caused by the novel coronavirus in Africa so far, according to a Reuters tally. And while the pandemic’s impact has been less acute than in the US, Europe and now India, experts say that Africa‘s largely unvaccinated population of over 1 billion remains vulnerable.

COVAX had already begun distributing millions of doses of the two-shot AstraZeneca vaccine to countries across Africa. But those initial shipments have now been largely exhausted, with around 80% having been administered as a first dose, according to the World Health Organisation (WHO).

The WHO said that most countries using COVAX will now surpass the 12-week maximum interval recommended between the first and second dose of AstraZeneca unless 20 million doses are delivered by the end of June and another 5 million in July.

“The supply gap could be closed if countries with adequate supplies set aside a percentage of vaccines for COVAX,” said Richard Mihigo, coordinator of the WHO’s Immunisation and Vaccines Development Programme in Africa.

A deal negotiated with Johnson & Johnson by the African Union should supply Africa with 400 million vaccine doses, beginning in the third quarter of this year.

Several countries’ health officials told Reuters they had yet to receive updated information on expected arrival dates for COVAX shots. Some are now weighing their options.

Ethiopia, for example, has received just 2.2 million of the 7.6 million AstraZeneca shots it was due to get through COVAX by the end of April.

“We were expecting some delays, but not to this scale. As a country we must search other options,” Muluken Yohannes, a senior adviser to Ethiopia’s health ministry, told Reuters.

(Reuters)

In New India, Can the Prime Minister Never Be Criticised?

With FIRs being registered against those who put up a poster critical of Narendra Modi, it appears the citizen does not have the fundamental right to express an unfavourable opinion of the government and the prime minister.

Some seventeen or so first information reports (FIRs) have been lodged by the Delhi Police against some jobless youths and daily wagers for putting up posters in Kalyanpuri in east Delhi. The poster asked the question of Prime Minister Narendra Modi as to why he had chosen to export vaccines needed by our own young people.

By no stretch of the public imagination may that text be construed as personally scurrilous or defamatory. The question explicitly pertains to a matter of administrative policy.

The ordinary citizen, especially now under an unprecedented national trauma, may be excused for wondering whether the government of the day must remain above public lament, however apocalyptic in lives lost for lack of oxygen.

If it is the case that, inter-alia, the government has come to mean the prime minister, it is for the reason that he is perceived to be in charge of everything, including the certification of the vaccine-taken hospital paper; that he never holds a press briefing while his cabinet remains a shadow-without-substance makes it all the more inevitable that common perceptions circulate as the presiding fact of India’s current executive culture.

This was not always so. A fact tellingly expressed in a recent editorial of the Saamana, organ of the Shiv Sena, the ruling BJP’s old and staunch ally at one time, who have consistently prided themselves for having taken a frontal part in the demolition of the erstwhile Babri mosque.

That editorial states that the country is running on “systems” created by Jawaharlal Nehru; and then goes on to name pretty much all former prime ministers from the Congress Party.

However cheeky the motivation of the text may have been, the comment remains historically pregnant, and it will be well for us to understand fully what things may have been involved in the “systems” the Sena organ speaks of.

For now, one aspect may be foregrounded: a willingness, however painful, to listen to opinion contrary to the official one, and to resist the tempatation to turn the prime minsiter’s post into a royalty beyond reproach, nowhere more piquantly expressed than in an anonymous article that appeared in the Modern Review of Calcutta in 1937, titled “We Want No Caesars.” That article, it turned out, was written by Nehru berating his own dictatorial tendencies.

We also recall that Nehru used often to call in the legendary cartoonist, Shankar, and admonish him “never to spare me”.

Jawaharlal Nehru. Photo: IISG/Flickr (CC BY-SA 2.0)

Come 2012, and posters acidly critical of the then prime minister, Manmohan Singh, were put up, as the BJP went to town on the so-called 2G scam (it was to transpire that the CBI ‘failed miserably‘ in proving the charges and acquittals followed dime a dozen).

Manmohan Singh was featured on a Time magazine cover as “The Underachiever”.

(It is germane to recall that, notwithstanding the critique of neo-liberal economics that we socialists voiced as the then United People’s Alliance under his leadership chose to embrace, following the Washington Consensus of 1990, between 2004 when the UPA came to power and 2014 when it lost power, the Indian economy grew nearly fourfold in absolute dollars numbers. Underachievement?)

It would be interesting to know how that growth of the GDP in absolute dollar numbers has grown from 2014 to date. All we have heard for the last seven years is how India is getting to be a $5 trillion economy—travelling in rhetoric but hardly arriving anywhere near.

Much as the Congress Party protested against that anti-prime minister campaign, one does not recall that any punitive executive actions were initiated, or FIRs lodged.

Criticism from within

The high-handed action taken against the jobless and the wage earners who put up the poster questioning Modi is made particularly a matter of wonderment in the light of the fact that criticisms of the government and of the prime minister have been forthcoming from within the “nationalist” camp.

To cite just a few instances: Anupam Kher, the doyen of actors and an ever-vocal supporter of the BJP and Modi has come forward to say that the government of the day is accountable for the tragedy that now besets the people of India, and that the time for image-building is not now.

Pretty drastic wouldn’t you say, coming from him.

Or, take the case of the academic, Makarand Paranjpe, who holds that India is not a secular country but one based on Dharma, and that a “civilisational” make-over of the nation has been overdue, has in an article in Hindustan Times remarked that Modi’s image has taken a beating; and then gone on to speak of the hubris and cloistered self-image of invincibility of Modi as some cause for this occurrence.

To top it all, Mohan Bhagwat, no less, has found it necessary to make his criticism known, remarking on the failure of the government (in Hindi, shasan, prashasan which surely include Mr Modi) to take heed of the warnings that were coming from the scientific community.

Surely, after such knowledge, what forgiveness.

And yet, it is much to be doubted that these internal criticisms of the government and the prime minister will yield either peremptory FIRs or instant arrests.

Posters that read “Modiji humare bachhon ki vaccine videsh kyun bhej diya (PM why did you send vaccines meant for our children to foreign countries)” were pasted in several parts of the city. Photo: Twitter

Question

Given these very contradictory circumstances, does the citizen not have the right to be told, perhaps by the judicial system, whether or not she has a fundamental right to express an unfavourable opinion of the government and the prime minister, provided of course such criticism is not defamatory or patently scurrilous. For example, it would be a below-the-belt thing to put up a poster questioning whether the prime minister’s inordinately long beard goes well with his post as prime minister—a matter entirely of his own choice as a free citizen, before anything else. But nobody has made such observations, as indeed they must not be made.

It may be remarked, all the same, that Modi has been a master of the snide himself; for a sample, his jibe on the floor of the Rajya Sabha against Manmohan Singh would not have been forgotten. Modi speculated that Manmohan Singh most likely wears a raincoat to his bath, remaining untainted by any corruption.

The impugned poster only poses an agonised question on why the vaccines were exported. It is another matter that we now know there was no expansive spiritual munificence was involved in those exports but a purely legal obligation under the international regime of intellectual property rights. Which, does, of course, raise the other question – one that sections of the media have been raising – why was that transaction projected as evidence of India’s great humanitarian culture as ordained, presumably, in the Geeta, as the prime minister told the nation on public television.

A heartening answer to the question that now distresses the public mind vis a vis the misuse of state power against the least expression of criticism may have come from the retired chief justice of the Allahabad high court in a ranging interaction with the Indian Express.

Justice Mathur, it will be recalled, had quashed NSA charges in many cases in Uttar Pradesh, as well as ruled against the “name and shame” measures adopted by the UP government against citizens who had protested the Citizenship Amendment Act.

Justice Mathur has minced no words about how citizens have come to be harassed and deprived of their fundamental right of free expression, both by state agencies and vigilante groups who work in tandem with them.

He has further underscored how “a majoritarian” mindset has come to rule even in such matters as appointments to the judiciary, remarking how, not the judiciary but the government shies away from appointing any person, however deserving, from a minority community to such appointments.

Thank you, Justice Mathur.

When the Constitution Commission in the US decided to include the right of Congress to impeach the president, it was done to obviate the possibility of the political system returning to a new monarchy.

Time that the largest democracy, as of this day, learnt some lessons.

Amidst COVID-19 Surge in India, Serum Institute ‘Legally Bound’ to Supply Vaccines to COVAX

This complicates the Pune-based operation’s efforts to divert all production to the Indian market, amidst a significant surge in cases in the country.

New Delhi: Amidst growing demand at home, the Serum Institute of India is legally bound to ship doses of the coronavirus vaccine to COVAX, a spokesperson of Gavi which is co-leading the global vaccine-sharing facility told Reuters.

This complicates the Pune-based operation’s efforts to divert all production to the Indian market, amidst a significant surge in cases in the country.

India had slowed down all major exports last month to fill the demand at home. On April 9, the case tally reached 1,30,60,542. Chief ministers of two states have said stored vaccines are likely to run out amidst the demand, while others have requested a lowering of the minimum vaccine age.

SII is the world’s biggest COVID-19 vaccine maker and manufactures the Oxford University-AstraZeneca vaccine, locally marketed as ‘Covishield’.

Between February and May, SII was supposed to have supplied COVAX with more than 100 million doses, excluding supplies for India. However, it has only received about 18.2 million.

COVAX is an initiative that aims to ensure equitable access to COVID-19 vaccines. It is led by UNICEF, Gavi, the Vaccine Alliance (formerly the Global Alliance for Vaccines and Immunization, or GAVI), the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and others organisations.

COVAX has delivered nearly 38.4 million doses of COVID-19 vaccines to 102 countries across six continents, six weeks after it began to roll out supplies, Gavi and WHO have said. It aims to deliver more than 2 billion doses this year.

Also read: Chart: Global Initiative to Provide Equitable Access to COVID-19 Vaccines Hits a Snag

Of the over 100 economies reached, 61 are among the 92 lower-income economies receiving vaccines funded through the Gavi COVAX Advance Market Commitment (AMC), PTI has reported.

“The agreement is legally binding and served as a basis for the first-round allocation document, which has been communicated to all participating economies,” a Gavi spokeswoman told Reuters.

The Reuters report notes that this agreement specified that Gavi would receive 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200 million committed, and the rest on option, from SII.

AstraZeneca has already issued it a legal notice over delays to other shipments. The African Union’s disease control body said on April 7 that it had dropped plans to secure AstraZeneca COVID-19 vaccines for its members from SII, the world’s biggest vaccine supplier, amid global shortfalls of the shot.

Gavi told Reuters that its pact with SII took effect when the World Health Organization approved the AstraZeneca shot on February 15.

“SII has pledged that, alongside supplying India, it will prioritise the COVAX multilateral solution for equitable distribution,” Gavi told the news agency.

The report mentioned that neither SII nor Gavi gave comments on how this situation will be mitigated.

India could resume vaccine exports by June, SII’s chief executive, Adar Poonawalla, had told reporters this week. On April 7,  Poonawalla sought Rs 3,000 crore grant from the government to ramp up capacity of the Covishield COVID-19 vaccine beyond 100 million doses a month that it will reach by the end of May, Financial Express reported.

Meanwhile, asserting that India has not imposed any export ban on anti-coronavirus vaccines, the Ministry of External Affairs on April 8 said the supply of made-in-India vaccines abroad would continue while also taking care of the country’s domestic requirements.

Within the country, the topic of vaccine exports and the politics surrounding it amidst a shortage of doses has taken centre stage.

The Aam Aadmi Party on April 9 blamed the Centre for sending vaccines to Pakistan and Afghanistan when, allegedly, “Due to a shortage of the vaccine doses, 109 vaccination centres in Pune, 26 in Mumbai and more than 700 in Odisha have been shut down.”